Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001104659-25-014273 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-14 | 2025-02-12 | RYTM | Smith Hunter C | CFO | S - Sale | $56.39 | -751 | 105.5K | -0.7% | -$42.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | S | D | 739 | $56.39 | 105,556 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-12 | S | D | 12 | $56.22 | 105,544 | D | — | — |